Cat Smith

I thank the hon. Gentleman for raising the case of his constituent Karen and her daughter, Bridget. I agree entirely that the time is now. He raises an important point that because this scandal has been going on for so long—the drug was first licensed in the 1970s—the babies who were harmed are no longer babies or even children, but adults with disabilities, whose parents are getting older every year. When I speak to those parents, one of their biggest anxieties is about who will look after their children when they no longer can. That is why we need compensation to be paid out sooner rather than later, because it has frankly already been too long. I turn to the case for compensation. The case for redress from the Government for the families affected by this maladministration has been conclusively made. This is not the first debate we have had in this Chamber on this matter, and there have been multiple reviews on it. In 2020, the Cumberlege review, established by the previous Prime Minister, Theresa May, found that “the state and manufacturers have an ethical responsibility to provide ex gratia payments to those who have experienced avoidable damage”. These payments should be made to cover costs such as “travel to medical appointments, respite breaks or emergency payments where a parent has to stop working to cover care.” I pay tribute to the former Prime Minister for her work on this issue, because she really is a doughty campaigner on this.